×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [23]
山东大学 [3]
水土保持研究所 [3]
西安交通大学 [2]
上海药物研究所 [2]
武汉大学 [2]
更多...
内容类型
期刊论文 [42]
会议论文 [8]
发表日期
2021 [1]
2020 [1]
2019 [8]
2018 [12]
2017 [10]
2016 [8]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共50条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
作者升序
作者降序
提交时间升序
提交时间降序
题名升序
题名降序
848 kHz repetition-rate narrowband dissipative soliton ps-pulsed Figure-9 fiber laser
期刊论文
OPTICS EXPRESS, 2021, 卷号: 29
作者:
Duan, Dian
;
Lu, Qiao
;
Wu, Bin
;
Mao, Yingqiu
;
Zhang, Zhen
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2021/08/30
Long-term stable 850-Hz linewidth single-longitudinal-mode ring cavity fiber laser using polarization-maintaining fiber
期刊论文
APPLIED PHYSICS B-LASERS AND OPTICS, 2020, 卷号: 126
作者:
Liu, Haowei
;
Lu, Qiao
;
Wei, Shanshan
;
Yao, Bo
;
Wei, Li
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2020/11/26
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
期刊论文
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:
Li, Qiao
;
Guan, Xiuwen
;
Chen, Shanshan
;
Yi, Zongbi
;
Lan, Bo
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2020/07/01
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase II open-label clinical study
期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 2
作者:
Wu, Xianghua
;
Qin, Shanshan
;
Yu, Hui
;
Luo, Zhiguo
;
Wang, Huijie
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/12/05
Albumin-bound paclitaxel
cisplatin
gemcitabine
first-line therapy
advanced non-small-cell lung cancer
Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
期刊论文
2019
作者:
Ma Fei
;
Guan Yanfang
;
Yi Zongbi
;
Chang Lianpeng
;
Li Qiao
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2020/01/03
PFS
cell-free circulating tumor DNA
metastasis breast cancer
trunk/branch resistance mutations
tumor heterogeneity
Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
期刊论文
2019, 卷号: 11, 页码: 4699-4706
作者:
Han, Yiqun
;
Wang, Jiayu
;
Liu, Weiming
;
Yuan, Peng
;
Li, Qing
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
trastuzumab
retreatment
HER2-positive cancer
metastatic cancer of the breast
progression therapy
Relationship between Ki67 and the efficacy of neoadjuvant chemotherapy: clinicopathological characteristics of luminal B breast cancer
期刊论文
2019, 卷号: 12, 期号: 5, 页码: 6044-6048
作者:
Wang, Jiayu
;
Sang, Die
;
Xu, Binghe
;
Yuan, Peng
;
Ma, Fei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Luminal B breast cancer
Ki-67
NCT
ROC curve
clinicopathological characteristics
prediction
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
期刊论文
2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:
Li Qiao
;
Guan Xiuwen
;
Chen Shanshan
;
Yi Zongbi
;
Lan Bo
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China
期刊论文
2019, 卷号: 19, 期号: 2, 页码: E370-E375
作者:
Lan, Bo
;
Ma, Fei
;
Han, Mei
;
Chen, Shanshan
;
Wang, Wenna
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/01/03
Chinese breast cancer patients
Disease free survival
Endocrine therapy
Single nucleotide polymorphism
UDP-glucuronosyltransferases 1A4
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 1
作者:
Guan, Xiuwen
;
Ma, Fei
;
Li, Chunxiao
;
Wu, Shiyang
;
Hu, Shangying
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Breast cancer
Circulating tumor cells
Epithelial-mesenchymal transition
Prognosis
Therapeutic implication
©版权所有 ©2017 CSpace - Powered by
CSpace